Ray Dalio's MDGL Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 27,785 shares of Madrigal Pharmaceuticals, Inc. (MDGL) worth $12.74 M, representing 0.05% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Ray Dalio has initiated a new position in MDGL, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Madrigal Pharmaceuticals (MDGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Madrigal Pharmaceuticals (MDGL) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +27,785 | New Buy | 27,785 | $458.66 |
Ray Dalio's Madrigal Pharmaceuticals Investment FAQs
Ray Dalio first purchased Madrigal Pharmaceuticals, Inc. (MDGL) in Q3 2025, acquiring 27,785 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Madrigal Pharmaceuticals, Inc. (MDGL) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Madrigal Pharmaceuticals, Inc. (MDGL) was in Q3 2025, adding 27,785 shares worth $12.74 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 27,785 shares of Madrigal Pharmaceuticals, Inc. (MDGL), valued at approximately $12.74 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Madrigal Pharmaceuticals, Inc. (MDGL) represents approximately 0.05% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Madrigal Pharmaceuticals, Inc. (MDGL) was 27,785 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.